We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00678314
First Posted: May 15, 2008
Last Update Posted: May 15, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Region Örebro County
May 13, 2008
May 15, 2008
May 15, 2008
January 2004
January 2006   (Final data collection date for primary outcome measure)
This study was done with the primary aim of assessing the efficacy (as calculated by pain intensity difference) of patient controlled regional analgesia (PCRA) technique against oral analgesics, which has been the standard of care at our hospital. [ Time Frame: 24 h ]
Same as current
No Changes Posted
Secondary objectives were to analyze the volume and dose of LA that should be given, patient satisfaction and the long-term outcome for patients treated with the PCRA technique. [ Time Frame: Up to 1 yr after surgery ]
Same as current
Not Provided
Not Provided
 
Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters
Patient Controlled Regional Analgesia Following Carpal Tunnel Release: A Double-Blind Study Using Distal Perineural Catheters
This study was done with the primary aim of assessing the efficacy (as calculated by pain intensity difference) of patient controlled regional analgesia (PCRA) technique against oral analgesics, which has been the standard of care at our hospital. Secondary objectives were to analyze the volume and dose of LA that should be given, patient satisfaction and the long-term outcome for patients treated with the PCRA technique.
Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Carpal Tunnel Syndrome
  • Drug: Ropivacaine 0.2%
    10 ml
  • Drug: Ropivacaine 0.75%
    3 ml
  • Drug: Normal saline
    10 ml
  • Active Comparator: Group A
    Intervention: Drug: Ropivacaine 0.2%
  • Active Comparator: Group B
    Intervention: Drug: Ropivacaine 0.75%
  • Placebo Comparator: Group C
    Intervention: Drug: Normal saline
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
88
February 2006
January 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with clinically established carpel tunnel syndrome
  • Surgery performed under local anesthesia

Exclusion Criteria:

  • Chronic pain requiring analgesics
Sexes Eligible for Study: All
18 Years to 75 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Sweden
 
 
NCT00678314
LMV 151:2003/9759
Yes
Not Provided
Not Provided
Dr Kurt Pettersson, Institution for Clinical Medicine
Region Örebro County
Not Provided
Principal Investigator: Kurt Pettersson, MD, PhD Institution for Clinical Medicine
Region Örebro County
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP